Surmodics | SRDX - Market Capitalization


Surmodics reported $393.5M in Market Capitalization this April of 2024, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 217.86B 15.25B Dec/2025
Align Technology USD 11.2B 2.13B Dec/2025
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 9.02B 4.25B Dec/2025
Artivion USD 2.18B 176M Dec/2025
Baxter International USD 9.82B 1.87B Dec/2025
Boston Scientific USD 141.35B 3.31B Dec/2025
EDAP TMS EUR 73M 11M Sep/2025
Edwards Lifesciences USD 49.47B 3.81B Dec/2025
Haemonetics USD 3.76B 1.44B Dec/2025
Heron Therapeutics USD 238M 7M Dec/2025
J&J USD 578.59B 562M Apr/2026
Merit Medical Systems USD 5.23B 297M Dec/2025
Nektar Therapeutics USD 14.34B 13.48B Apr/2026
Option Care Health USD 5.06B 552M Dec/2025
Stryker USD 134.41B 6.92B Dec/2025